EarningsCENTRALPHL
CENTRALPHL Earnings Update
Announcement summary
- What happened
- CENTRALPHL published a corporate disclosure on 30 April 2026. Read the full announcement for details.
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. (0.09) for January-March 2026 as against Tk. (0.10) for January-March 2025; EPS was Tk. (0.23) for July 2025-March 2026 as against Tk. (0.24) for July 2024-March 2025. NOCFPS was Tk. (0.01) for July 2025-March 2026 as against Tk. (0.00) for July 2024-March 2025. NAV per share was Tk. 6.64 as on March 31, 2026 and Tk. 6.87 as on June 30, 2025.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 69f2d1a4f35b0b05d2cff8a4
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.